Treatment and Prevention of Osteoporosis during COVID-19 Outbreak: Management and Adherence to Treatment Guidelines

Rishabha Malviya1, Akanksha Sharma1, Ramji Gupta1, Rajendra Awasthi2, *
1 Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Plot No. 02, Sector 17-A, Greater Noida, Gautam Buddha Nagar, Uttar Pradesh, India
2 Amity Institute of Pharmacy, Amity University Uttar Pradesh, Sector - 125, Noida, Uttar Pradesh, India

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 2003
Abstract HTML Views: 1593
PDF Downloads: 161
ePub Downloads: 119
Total Views/Downloads: 3876
Unique Statistics:

Full-Text HTML Views: 489
Abstract HTML Views: 312
PDF Downloads: 128
ePub Downloads: 66
Total Views/Downloads: 995

Creative Commons License
© 2020 Malviya et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at Amity Institute of Pharmacy, Amity University Uttar Pradesh, Sector - 125, Noida, Uttar Pradesh, India; Tel: +91-9459234530; E-mail: awasthi02@gmail.com


A total of 219 countries, areas, or territories have globally witnessed the existence of a novel Coronavirus (COVID-19) pandemic over the last few months, which posed serious threats to human health. The viral incubation period varies from 2 to 14 days. It has been observed that osteoporosis patients are likely to be at high risk of COVID-19 contracting sequelae. Osteoporosis is a chronic condition that reduces bone strength and increases the risk of fracture. Osteoporosis typically requires sustained therapeutic intervention to reduce the risks of further bone loss, structural integrity impairment and incidence of fractures. In the COVID-19 pandemic, diagnosis of chronic osteoporosis conditions should not become an unwanted casualty. Metabolic bone condition may lead to complications in COVID-19 infected patients. Orthopaedic doctors are being redeployed in different hospitals to treat COVID-19 infected patients. Thus, the orthopaedics community needs compulsory training to understand the symptoms of this condition. Orthopaedics surgery and trauma surgery are challenging in a hospital setup with limited availability of hospital staff and operating facilities. Clinicians must respond to the challenges raised by this crisis and consider ways of continuing to help patients with chronic diseases with their substantive morbidity and mortality.

Keywords: Bone disorder, COVID-19, Infection, Osteoporosis, MERS-CoV, SARS-CoV2.